Head to head
Clorox vs Procter & Gamble
Side-by-side on the measures that matter, with a plain-English read. Full detail: CLX · PG
CLX
Clorox
82.21-1.57%
1-year price shape — -29% over the period
Quant Rating E · 13/100
vs
PG
Procter & Gamble
147.82-0.40%
1-year price shape — -0% over the period
Quant Rating C · 40/100
1-year performance, rebased to 100
Procter & Gamble edges it on the scoreable measures. Procter & Gamble has the highest Quant Rating (40); Procter & Gamble has done best over the past year (-0%); Procter & Gamble earns the most per share.
| CLX | PG | |
|---|---|---|
| Snapshot | ||
| Sector | Household & Personal Products | -- |
| Last price | 82.21 | 147.82 |
| Change today | -1.57% | -0.40% |
| 1-year return | -28.6% | -0.2% |
| Market cap | $9.94B | $343.34B |
| 52-week range | 79.12 – 125.83 | 134.62 – 164.77 |
| Valuation | ||
| P/E (TTM) | 17.09 | 22.33 |
| P/E percentile, own 5-yr range | 12th | 14th |
| P/B | 110.50 | 6.44 |
| Dividend yield | 6.03% | 2.88% |
| Profitability & growth | ||
| EPS (TTM) | 4.81 | 6.62 |
| Net profit (TTM) | $581.71M | $15.38B |
| Revenue (TTM) | $6.72B | $87.03B |
| Revenue growth (YoY) | -2.0% | +1.5% |
| Gross margin | 42.3% | 50.2% |
| Operating margin | 13.2% | 22.7% |
| Net margin | 8.7% | 18.1% |
| Free cash flow (TTM) | $405.00M | $15.15B |
| Ownership & sentiment | ||
| Institutional ownership | 87.1% | 71.5% |
| Insider activity (12mo) | 38 buy / 12 sell | 33 buy / 17 sell |
| Short interest (% of float) | 7.0% | 1.0% |
| Analyst consensus | 75% hold / 25% sell (12) | 53% buy / 47% hold (17) |
| Analyst price target | $94 (+14%) | $160 (+8%) |
| StockVane view | ||
| StockVane Quant Rating | E (13) | C (40) |
| Company | ||
| Employees | 7,600 | 104,000 |
| Founded | 1913 | 1837 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.